INTRODUCTION: Polypharmacy, defined as the use of multiple drugs or more than are medically necessary, is a growing concern for older adults. MEDLINE and EMBASE databases were searched from January 1, 1986 to June 30, 2013) to identify relevant articles in people aged > 65 years. AREAS COVERED: We present information about: i) prevalence of…
Expert Opinion on Drug Safety Template
Write in a clean editor, then format for Expert Opinion on Drug Safety in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Expert Opinion on Drug Safety format
Expert Opinion on Drug Safety is a peer-reviewed journal published by Taylor & Francis, covering Pharmacovigilance and Adverse Drug Reactions, Drug-Induced Adverse Reactions, Diabetes Treatment and Management.
| Publisher | Taylor & Francis |
|---|---|
| Reference style | Author–year (Chicago, T&F) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Expert Opinion on Drug Safety 12 (3): 45–58.
Formats any DOI in Expert Opinion on Drug Safety style. No sign-up. |
| Publishes research in | Pharmacovigilance and Adverse Drug Reactions Drug-Induced Adverse Reactions Diabetes Treatment and Management Rheumatoid Arthritis Research and Therapies Pharmaceutical studies and practices |
| ISSN | 1474-0338 |
| Citation impact (2-yr) | 3.16 |
| h-index | 111 |
| i10-index | 1,755 |
| Total citations | 80,212 |
| Top institutions publishing here | Weatherford College |
| Journal website | informahealthcare.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Expert Opinion on Drug Safety per year
Citation impact of Expert Opinion on Drug Safety by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Expert Opinion on Drug Safety
INTRODUCTION: Glucocorticoids represent the standard therapy for reducing inflammation and immune activation in various diseases. However, as with any potent medication, they are not without side effects. Glucocorticoid-associated side effects may involve most major organ systems. Musculoskeletal, gastrointestinal, cardiovascular, endocrine, neuropsychiatric, dermatologic, ocular, and immunologic side effects are all possible. AREAS COVERED: This article analyzes…
Better known as Taxol (Bristol-Myers Squibb), paclitaxel is the first member of the taxane family to be used in cancer chemotherapy. The taxanes exert their cytotoxic effect by arresting mitosis through microtubule stabilization, resulting in cellular apoptosis. The use of paclitaxel as a chemotherapeutic agent has become a broadly accepted option in the treatment of…
INTRODUCTION: The globalization of the pharmaceutical supply chain has introduced new challenges, chief among them, fighting the international criminal trade in fake medicines. As the manufacture, supply, and distribution of drugs becomes more complex, so does the need for innovative technology-based solutions to protect patients globally. Areas covered: We conducted a multidisciplinary review of the…
INTRODUCTION: Hydroxychloroquine (HCQ) is an alkalinizing lysosomatropic drug that accumulates in lysosomes where it inhibits some important functions by increasing the pH. HCQ has proved to be effective in a number of autoimmune diseases including systemic lupus erythematosus (SLE). Areas covered: In this review the mechanisms of action, the efficacy, and the safety of HCQ…